Samantha Haeberlein
Director/Board Member en VIGIL NEUROSCIENCE, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Samantha Budd Haeberlein is currently the Director at The Boston Home.
She also holds current positions as an Independent Director at Vigil Neuroscience, Inc. and as a Senior Advisor at Intermediate Capital Group Plc (Private Equity).
In the past, she worked as a Director at Rodin Therapeutics, Inc. in 2016 and as the Vice President-Clinical Development at Biogen, Inc. from 2015 to 2020.
Dr. Haeberlein received her undergraduate and doctorate degrees from the University of Dundee.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VIGIL NEUROSCIENCE, INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Samantha Haeberlein
| Empresas | Cargo | Inicio |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Director/Board Member | 08/05/2023 |
The Boston Home
 The Boston Home Medical/Nursing ServicesHealth Services The Boston Home serves adults with multiple sclerosis and other progressive neurological diseases. It offers wheelchair enhancement centre, B fit day program and rehabilitation services. The company was founded in 1881 and is headquartered in Boston, MA. | Director/Board Member | - |
Intermediate Capital Group Plc (Private Equity)
 Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom. | Consultant / Advisor | 01/09/2023 |
Antiguos cargos conocidos de Samantha Haeberlein.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2020 |
Rodin Therapeutics, Inc.
 Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Director/Board Member | 01/12/2016 |
Formación de Samantha Haeberlein.
| University Of Dundee | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Intermediate Capital Group Plc (Private Equity)
Intermediate Capital Group Plc (Private Equity) Investment ManagersFinance Intermediate Capital Group Plc (Private Equity) (ICG) is a private equity division of Intermediate Capital Group Plc founded in 1989. The firm is headquartered in London, United Kingdom. | Finance |
The Boston Home
The Boston Home Medical/Nursing ServicesHealth Services The Boston Home serves adults with multiple sclerosis and other progressive neurological diseases. It offers wheelchair enhancement centre, B fit day program and rehabilitation services. The company was founded in 1881 and is headquartered in Boston, MA. | Health Services |
Rodin Therapeutics, Inc.
Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Samantha Haeberlein
